Synairgen
is a drug discovery and development company that focuses on developing novel therapies for respiratory diseases... Read moreSynairgen
is a drug discovery and development company that focuses on developing novel therapies for respiratory diseases... Read more
News
Nov 12, 2025
OINDPnews
Synairgen: Aerogen to develop custom nebulizer for delivery of Synairgen's SNG001 inhaled interferon-beta
Oct 01, 2025
Marketscreener
Synairgen: Synairgen plc Reports Earnings Results for the Full Year Ended December 31, 2024
Apr 03, 2025
Proactive Investors
Synairgen: Synairgen shares stay tradeable post-delisting, as top investor waives restrictions
Mar 11, 2025
Proactive Investors
Synairgen: Synairgen becomes the latest company to eye the AIM exit door
Feb 13, 2025
Global Legal Chronicle
Synairgen: Synairgen plc's 18 Million Fundraising
Jan 16, 2025
European Biotechnology
Synairgen: Synairgen raises 18m for Phase 2 INVENT trial of SNG001
Dec 21, 2024
Proactive Investors
Synairgen: Synairgen CEO on funding phase 2 trial for SNG001
Dec 21, 2024
Proactive Investors
Synairgen: Synairgen backer ready to pump 18-19 million into phase II trial
Sep 26, 2024
Marketscreener
Synairgen: Synairgen plc Reports Earnings Results for the Half Year Ended June 30, 2024
Sep 18, 2024
Proactive Investors
Synairgen: Synairgen appoints inhaled drug development expert as chairman
Synairgen Competitors
1
2
3
4
5
6
7
8
9
10